id stringlengths 11 11 | tags stringlengths 10 777 | text stringlengths 2 1.5k | dataset_num int64 1 3 | tokens list | ner_tags list |
|---|---|---|---|---|---|
NCT02074631 | 1:20:chronic_disease,, | Renal insufficiency, defined as creatinine level greater than the upper limit of normal for age | 3 | [
"Renal",
"insufficiency",
",",
"defined",
"as",
"creatinine",
"level",
"greater",
"than",
"the",
"upper",
"limit",
"of",
"normal",
"for",
"age"
] | [
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02261519 | ,,111:125:treatment | at least 6 times duration of the reported half life or minimum four (4) months for other depot or long-acting antipsychotics | 3 | [
"at",
"least",
"6",
"times",
"duration",
"of",
"the",
"reported",
"half",
"life",
"or",
"minimum",
"four",
"(",
"4",
")",
"months",
"for",
"other",
"depot",
"or",
"long-acting",
"antipsychotics"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02237183 | 43:62:chronic_disease, | Participants must not have used any other investigation agent within the last six months | 3 | [
"Participants",
"must",
"not",
"have",
"used",
"any",
"other",
"investigation",
"agent",
"within",
"the",
"last",
"six",
"months"
] | [
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0
] |
NCT02776761 | 10:20:chronic_disease,10:26:treatment,21:26:treatment | Negative hantavirus PsVNA test result at screening | 3 | [
"Negative",
"hantavirus",
"PsVNA",
"test",
"result",
"at",
"screening"
] | [
0,
1,
1,
0,
0,
0,
0
] |
NCT00472329 | ,,49:69:treatment | DLCO <35% of predicted, or receiving continuous supplementary oxygen | 3 | [
"DLCO",
"<",
"35",
"%",
"of",
"predicted",
",",
"or",
"receiving",
"continuous",
"supplementary",
"oxygen"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT01639508 | ,,87:102:treatment,110:118:chronic_disease,156:159:chronic_disease | The subject has not recovered to baseline or CTCAE ≤ Grade 1 from toxicity due to all prior therapies except alopecia and other non-clinically significant AEs | 3 | [
"The",
"subject",
"has",
"not",
"recovered",
"to",
"baseline",
"or",
"CTCAE",
"≤",
"Grade",
"1",
"from",
"toxicity",
"due",
"to",
"all",
"prior",
"therapies",
"except",
"alopecia",
"and",
"other",
"non-clinically",
"significant",
"AEs"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
2,
0,
0,
0,
0,
2
] |
NCT02774421 | 1:26:cancer | supratentorial ependymoma | 3 | [
"supratentorial",
"ependymoma"
] | [
3,
3
] |
NCT02576444 | ,,,124:134:treatment | Women of child-bearing potential must have a negative pregnancy test (urine or serum) within 28 days prior to starting the study drug | 3 | [
"Women",
"of",
"child-bearing",
"potential",
"must",
"have",
"a",
"negative",
"pregnancy",
"test",
"(",
"urine",
"or",
"serum",
")",
"within",
"28",
"days",
"prior",
"to",
"starting",
"the",
"study",
"drug"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02784535 | 1:22:chronic_disease | Narrow-angle glaucoma | 3 | [
"Narrow-angle",
"glaucoma"
] | [
2,
2
] |
NCT03084640 | 32:51:chronic_disease,55:79:chronic_disease,112:125:treatment | have a best response of either Stable Disease (SD) or Progressive Disease (PD) per RECIST Version 1.1 while on pembrolizumab | 3 | [
"have",
"a",
"best",
"response",
"of",
"either",
"Stable",
"Disease",
"(",
"SD",
")",
"or",
"Progressive",
"Disease",
"(",
"PD",
")",
"per",
"RECIST",
"Version",
"1.1",
"while",
"on",
"pembrolizumab"
] | [
0,
0,
0,
0,
0,
0,
2,
2,
2,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02143726 | 29:51:treatment | have received any number of prior lines of therapy | 3 | [
"have",
"received",
"any",
"number",
"of",
"prior",
"lines",
"of",
"therapy"
] | [
0,
0,
0,
0,
0,
1,
1,
1,
1
] |
NCT01917721 | 26:28:chronic_disease,58:62:treatment,99:113:treatment | Patients with refractory KD after initial treatment with IVIG and dilated coronary arteries on an echocardiogram during the first month of KD | 3 | [
"Patients",
"with",
"refractory",
"KD",
"after",
"initial",
"treatment",
"with",
"IVIG",
"and",
"dilated",
"coronary",
"arteries",
"on",
"an",
"echocardiogram",
"during",
"the",
"first",
"month",
"of",
"KD"
] | [
0,
0,
0,
2,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0
] |
NCT02995330 | 26:56:cancer | Histologically-confirmed adenocarcinoma of the prostate | 3 | [
"Histologically-confirmed",
"adenocarcinoma",
"of",
"the",
"prostate"
] | [
0,
3,
3,
3,
3
] |
NCT01349101 | 35:45:cancer,62:73:cancer,99:108:treatment | Patients with evidence of another malignancy, exclusive of a skin cancer that requires only local treatment, should not be enrolled on this protocol | 3 | [
"Patients",
"with",
"evidence",
"of",
"another",
"malignancy",
",",
"exclusive",
"of",
"a",
"skin",
"cancer",
"that",
"requires",
"only",
"local",
"treatment",
",",
"should",
"not",
"be",
"enrolled",
"on",
"this",
"protocol"
] | [
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
3,
3,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02217709 | 26:56:cancer | Histologically confirmed adenocarcinoma of the prostate | 3 | [
"Histologically",
"confirmed",
"adenocarcinoma",
"of",
"the",
"prostate"
] | [
0,
0,
3,
3,
3,
3
] |
NCT02514083 | 25:39:chronic_disease,94:100:chronic_disease,108:124:chronic_disease | Evidence of progressive marrow failure as manifested by the development of, or worsening of, anemia and/or thrombocytopenia | 3 | [
"Evidence",
"of",
"progressive",
"marrow",
"failure",
"as",
"manifested",
"by",
"the",
"development",
"of",
",",
"or",
"worsening",
"of",
",",
"anemia",
"and/or",
"thrombocytopenia"
] | [
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
0,
2
] |
NCT02506192 | 8:32:chronic_disease | Has an chronic/active infection | 3 | [
"Has",
"an",
"chronic/active",
"infection"
] | [
0,
0,
2,
2
] |
NCT02589340 | 19:29:treatment | Unable to swallow study drug (capsule) | 3 | [
"Unable",
"to",
"swallow",
"study",
"drug",
"(",
"capsule",
")"
] | [
0,
0,
0,
1,
1,
0,
0,
0
] |
NCT02562430 | 12:27:chronic_disease, | history of eating disorder unless if in remission for ≥5 years prior to screening and presenting no current electrolyte abnormalities | 3 | [
"history",
"of",
"eating",
"disorder",
"unless",
"if",
"in",
"remission",
"for",
"≥5",
"years",
"prior",
"to",
"screening",
"and",
"presenting",
"no",
"current",
"electrolyte",
"abnormalities"
] | [
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03076333 | 19:36:chronic_disease | Poorly controlled diabetes mellitus | 3 | [
"Poorly",
"controlled",
"diabetes",
"mellitus"
] | [
0,
0,
2,
2
] |
NCT02759120 | 21:39:allergy_name | Contraindicated for antibiotic therapy | 3 | [
"Contraindicated",
"for",
"antibiotic",
"therapy"
] | [
0,
0,
4,
4
] |
NCT02095184 | 30:40:cancer,,76:89:cancer,112:138:cancer,142:147:cancer,148:166:cancer | Previous or current systemic malignancy within the past 3 years other than breast cancer or adequately treated cervical carcinoma in situ or basal/squamous carcinoma of the skin | 3 | [
"Previous",
"or",
"current",
"systemic",
"malignancy",
"within",
"the",
"past",
"3",
"years",
"other",
"than",
"breast",
"cancer",
"or",
"adequately",
"treated",
"cervical",
"carcinoma",
"in",
"situ",
"or",
"basal/squamous",
"carcinoma",
"of",
"the",
"skin"
] | [
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
3,
3,
0,
0,
0,
3,
3,
3,
3,
0,
3,
3,
0,
0,
0
] |
NCT02395393 | 34:57:allergy_name | to have any contraindications to transbronchial biopsies | 3 | [
"to",
"have",
"any",
"contraindications",
"to",
"transbronchial",
"biopsies"
] | [
0,
0,
0,
0,
0,
4,
4
] |
NCT02080221 | 41:73:cancer | Pathologically or cytological confirmed pancreatic ductal adenocarcinoma | 3 | [
"Pathologically",
"or",
"cytological",
"confirmed",
"pancreatic",
"ductal",
"adenocarcinoma"
] | [
0,
0,
0,
0,
3,
3,
3
] |
NCT02310399 | 36:59:treatment | Willing to receive the appropriate meningitis vaccinations | 3 | [
"Willing",
"to",
"receive",
"the",
"appropriate",
"meningitis",
"vaccinations"
] | [
0,
0,
0,
0,
0,
1,
1
] |
NCT02092324 | 42:56:treatment,93:96:cancer,100:104:cancer | Subjects must be able to discontinue any drug treatment aimed at lowering disease burden in CNL or aCML | 3 | [
"Subjects",
"must",
"be",
"able",
"to",
"discontinue",
"any",
"drug",
"treatment",
"aimed",
"at",
"lowering",
"disease",
"burden",
"in",
"CNL",
"or",
"aCML"
] | [
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
3,
0,
3
] |
NCT01985087 | 1:4:chronic_disease,41:63:treatment,142:154:treatment | HIV-positive individuals on combination antiretroviral therapy are ineligible because of the potential for pharmacokinetic interactions with temozolomide | 3 | [
"HIV-positive",
"individuals",
"on",
"combination",
"antiretroviral",
"therapy",
"are",
"ineligible",
"because",
"of",
"the",
"potential",
"for",
"pharmacokinetic",
"interactions",
"with",
"temozolomide"
] | [
2,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02664168 | 21:51:treatment | Subjects undergoing primary total joint procedures | 3 | [
"Subjects",
"undergoing",
"primary",
"total",
"joint",
"procedures"
] | [
0,
0,
1,
1,
1,
1
] |
NCT03135145 | ,222:243:treatment | Gross Motor Function Classification System levels I (walk and run in the community with only limitations in balance, coordination and speed) and V (use wheelchair to maintain sitting and for whole body mobility) prior to surgical intervention | 3 | [
"Gross",
"Motor",
"Function",
"Classification",
"System",
"levels",
"I",
"(",
"walk",
"and",
"run",
"in",
"the",
"community",
"with",
"only",
"limitations",
"in",
"balance",
",",
"coordination",
"and",
"speed",
")",
"and",
"V",
"(",
"use",
"wheelchair",
"to"... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT02995590 | 12:38:chronic_disease,40:61:chronic_disease,66:75:chronic_disease | History of congenital cardiac disease, chronic renal failure, or cirrhosis | 3 | [
"History",
"of",
"congenital",
"cardiac",
"disease",
",",
"chronic",
"renal",
"failure",
",",
"or",
"cirrhosis"
] | [
0,
0,
2,
2,
2,
0,
2,
2,
2,
0,
0,
2
] |
NCT02760498 | ,,,122:132:treatment | Immunosuppressive corticosteroid doses (>10 mg prednisone daily or equivalent) within 4 weeks prior to the first dose of cemiplimab | 3 | [
"Immunosuppressive",
"corticosteroid",
"doses",
"(",
">",
"10",
"mg",
"prednisone",
"daily",
"or",
"equivalent",
")",
"within",
"4",
"weeks",
"prior",
"to",
"the",
"first",
"dose",
"of",
"cemiplimab"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02451423 | 19:24:cancer | For subjects with NMIBC, BCG-refractory or BCG-resistant disease | 3 | [
"For",
"subjects",
"with",
"NMIBC",
",",
"BCG-refractory",
"or",
"BCG-resistant",
"disease"
] | [
0,
0,
0,
3,
0,
0,
0,
0,
0
] |
NCT01804465 | 9:48:treatment | Current treatment with systemic steroid therapy | 3 | [
"Current",
"treatment",
"with",
"systemic",
"steroid",
"therapy"
] | [
0,
1,
1,
1,
1,
1
] |
NCT02512497 | 30:58:chronic_disease,60:89:chronic_disease,91:109:chronic_disease,114:128:chronic_disease,164:219:treatment | A known history of sustained ventricular tachycardia (VT), ventricular fibrillation (VF), Torsade de Pointes, or cardiac arrest unless currently addressed with an automatic implantable cardioverter defibrillator (AICD) | 3 | [
"A",
"known",
"history",
"of",
"sustained",
"ventricular",
"tachycardia",
"(",
"VT",
")",
",",
"ventricular",
"fibrillation",
"(",
"VF",
")",
",",
"Torsade",
"de",
"Pointes",
",",
"or",
"cardiac",
"arrest",
"unless",
"currently",
"addressed",
"with",
"an",
"... | [
0,
0,
0,
0,
0,
2,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
2,
0,
0,
2,
2,
0,
0,
0,
0,
0,
1,
1,
1,
1,
1,
0,
0
] |
NCT01817751 | 24:35:chronic_disease,43:57:chronic_disease,69:72:treatment, | Correct any identified hypokalemia and/or hypomagnesemia and repeat ECG to confirm exclusion of patient due to QTc | 3 | [
"Correct",
"any",
"identified",
"hypokalemia",
"and/or",
"hypomagnesemia",
"and",
"repeat",
"ECG",
"to",
"confirm",
"exclusion",
"of",
"patient",
"due",
"to",
"QTc"
] | [
0,
0,
0,
2,
0,
2,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03158116 | 68:90:chronic_disease | One of previous 3 tracheostomy tube aspirate cultures positive for Pseudomonas aeruginosa | 3 | [
"One",
"of",
"previous",
"3",
"tracheostomy",
"tube",
"aspirate",
"cultures",
"positive",
"for",
"Pseudomonas",
"aeruginosa"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2
] |
NCT02472834 | ,,107:130:treatment | Women of childbearing potential must be practicing barrier or oral contraception, for the duration of the study-related treatment, or be documented as surgically sterile or one year post-menopausal | 3 | [
"Women",
"of",
"childbearing",
"potential",
"must",
"be",
"practicing",
"barrier",
"or",
"oral",
"contraception",
",",
"for",
"the",
"duration",
"of",
"the",
"study-related",
"treatment",
",",
"or",
"be",
"documented",
"as",
"surgically",
"sterile",
"or",
"one",... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT01140087 | 35:57:treatment | Facial defect or injury requiring facial transplantation as determined by the treating Plastic and Reconstructive Surgeon | 3 | [
"Facial",
"defect",
"or",
"injury",
"requiring",
"facial",
"transplantation",
"as",
"determined",
"by",
"the",
"treating",
"Plastic",
"and",
"Reconstructive",
"Surgeon"
] | [
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02192359 | 34:44:treatment,49:54:cancer,49:64:treatment,70:95:treatment,177:186:treatment,213:230:treatment,235:247:treatment | Participant must be in need of a craniotomy for tumor resection or a stereotactic brain biopsy for the purpose of diagnosis or differentiating between tumor progression versus treatment-induced effects following radiation therapy +/- chemotherapy | 3 | [
"Participant",
"must",
"be",
"in",
"need",
"of",
"a",
"craniotomy",
"for",
"tumor",
"resection",
"or",
"a",
"stereotactic",
"brain",
"biopsy",
"for",
"the",
"purpose",
"of",
"diagnosis",
"or",
"differentiating",
"between",
"tumor",
"progression",
"versus",
"trea... | [
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
1,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
1,
1,
0,
1
] |
NCT01072370 | 19:37:chronic_disease | Presence of major congenital anomaly | 3 | [
"Presence",
"of",
"major",
"congenital",
"anomaly"
] | [
0,
0,
0,
2,
2
] |
NCT03085095 | ,,107:128:treatment,,163:175:treatment,177:188:treatment,193:218:treatment | Has a serum PSA concentration at the Screening visit of > 2.0 ng/mL (2.0 μg/L), or, when applicable, post radical prostatectomy of > 0.2 ng/mL (0.2 μg/L) or post radiotherapy, cryotherapy, or high frequency ultrasound > 2.0 ng/mL (2.0 μg/L) above the post interventional nadir | 3 | [
"Has",
"a",
"serum",
"PSA",
"concentration",
"at",
"the",
"Screening",
"visit",
"of",
">",
"2.0",
"ng/mL",
"(",
"2.0",
"μg/L",
")",
",",
"or",
",",
"when",
"applicable",
",",
"post",
"radical",
"prostatectomy",
"of",
">",
"0.2",
"ng/mL",
"(",
"0.2",
"μ... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02013154 | 1:23:treatment,27:39:treatment,,,89:101:treatment,105:116:treatment | Treatment with surgery or chemotherapy within 21 days prior to study entry (42 days for nitrosoureas or mitomycin C) | 3 | [
"Treatment",
"with",
"surgery",
"or",
"chemotherapy",
"within",
"21",
"days",
"prior",
"to",
"study",
"entry",
"(",
"42",
"days",
"for",
"nitrosoureas",
"or",
"mitomycin",
"C",
")"
] | [
1,
1,
1,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
1,
1,
0
] |
NCT02828618 | 11:25:cancer | Recurrent ovarian cancer | 3 | [
"Recurrent",
"ovarian",
"cancer"
] | [
0,
3,
3
] |
NCT01959698 | ,18:31:treatment | >= 2 weeks since major surgery | 3 | [
">",
"=",
"2",
"weeks",
"since",
"major",
"surgery"
] | [
0,
0,
0,
0,
0,
1,
1
] |
NCT02472834 | 14:32:treatment | Prescribed a dialysis treatment time of 4 hours per session | 3 | [
"Prescribed",
"a",
"dialysis",
"treatment",
"time",
"of",
"4",
"hours",
"per",
"session"
] | [
0,
0,
1,
1,
0,
0,
0,
0,
0,
0
] |
NCT02508038 | 14:40:chronic_disease | uncontrolled cardiac rhythm disturbance | 3 | [
"uncontrolled",
"cardiac",
"rhythm",
"disturbance"
] | [
0,
2,
2,
2
] |
NCT02203695 | 12:19:chronic_disease,46:56:treatment,123:129:chronic_disease,131:151:cancer,153:169:cancer | History of seizure or any condition that may predispose to seizure including, but not limited to underlying brain injury, stroke, primary brain tumors, brain metastases, or alcoholism | 3 | [
"History",
"of",
"seizure",
"or",
"any",
"condition",
"that",
"may",
"predispose",
"to",
"seizure",
"including",
",",
"but",
"not",
"limited",
"to",
"underlying",
"brain",
"injury",
",",
"stroke",
",",
"primary",
"brain",
"tumors",
",",
"brain",
"metastases",
... | [
0,
0,
2,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
0,
2,
0,
3,
3,
3,
0,
0,
0,
0,
0,
0
] |
NCT02553460 | 13:24:treatment | one dose of vincristine | 3 | [
"one",
"dose",
"of",
"vincristine"
] | [
0,
0,
0,
1
] |
NCT03169881 | 1:33:chronic_disease | Hemorrhagic or hemolytic disease | 3 | [
"Hemorrhagic",
"or",
"hemolytic",
"disease"
] | [
2,
2,
2,
2
] |
NCT02245841 | 41:51:chronic_disease | Patients with acutely active or chronic infections | 3 | [
"Patients",
"with",
"acutely",
"active",
"or",
"chronic",
"infections"
] | [
0,
0,
0,
0,
0,
0,
2
] |
NCT02502006 | 11:17:treatment,21:42:treatment,44:66:treatment,70:93:treatment, | Has taken NSAIDs or anti-secretory agents (proton pump inhibitors or H2 receptor antagonists) within 14 days prior to study drug administration | 3 | [
"Has",
"taken",
"NSAIDs",
"or",
"anti-secretory",
"agents",
"(",
"proton",
"pump",
"inhibitors",
"or",
"H2",
"receptor",
"antagonists",
")",
"within",
"14",
"days",
"prior",
"to",
"study",
"drug",
"administration"
] | [
0,
0,
1,
0,
1,
1,
0,
1,
1,
1,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03049969 | 5:33:chronic_disease,41:47:chronic_disease,56:62:chronic_disease,65:73:chronic_disease,75:86:chronic_disease,103:111:chronic_disease,142:154:chronic_disease | Any skin disorder/sensitive skin (e.g., eczema, severe rashes), blisters, open wounds, burn including sunburns, cuts or irritation, or other skin defects which compromise the integrity of the skin at or near stimulation locations (where electrodes are placed) | 3 | [
"Any",
"skin",
"disorder/sensitive",
"skin",
"(",
"e.g.",
",",
"eczema",
",",
"severe",
"rashes",
")",
",",
"blisters",
",",
"open",
"wounds",
",",
"burn",
"including",
"sunburns",
",",
"cuts",
"or",
"irritation",
",",
"or",
"other",
"skin",
"defects",
"wh... | [
0,
2,
2,
2,
0,
0,
0,
2,
0,
0,
2,
0,
0,
2,
0,
2,
2,
0,
0,
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02991677 | 1:24:chronic_disease | Coronary artery disease | 3 | [
"Coronary",
"artery",
"disease"
] | [
2,
2,
2
] |
NCT01568255 | 1:21:chronic_disease | Renal osteodystrophy | 3 | [
"Renal",
"osteodystrophy"
] | [
2,
2
] |
NCT01624090 | 13:40:treatment | Patients on therapeutic anticoagulation | 3 | [
"Patients",
"on",
"therapeutic",
"anticoagulation"
] | [
0,
0,
1,
1
] |
NCT02389309 | 1:10:treatment,12:20:treatment,22:32:treatment,34:41:treatment,43:54:treatment,56:67:treatment,69:81:treatment,83:95:treatment,97:109:treatment,111:122:treatment | Cisapride, bepridil, droperidol, arsenic, chloroquine, domperidone, halofantrine, levomethadyl, sparfloxacin, lidoflazine | 3 | [
"Cisapride",
",",
"bepridil",
",",
"droperidol",
",",
"arsenic",
",",
"chloroquine",
",",
"domperidone",
",",
"halofantrine",
",",
"levomethadyl",
",",
"sparfloxacin",
",",
"lidoflazine"
] | [
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1,
0,
1
] |
NCT02213497 | ,,,,,171:183:treatment | Women of child-bearing potential as long as she agrees to use a recognized method of birth control (e.g. oral contraceptive, IUD, condoms or other barrier methods etc.). Hysterectomy or menopause must be clinically documented | 3 | [
"Women",
"of",
"child-bearing",
"potential",
"as",
"long",
"as",
"she",
"agrees",
"to",
"use",
"a",
"recognized",
"method",
"of",
"birth",
"control",
"(",
"e.g",
".",
"oral",
"contraceptive",
",",
"IUD",
",",
"condoms",
"or",
"other",
"barrier",
"methods",
... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0
] |
NCT02318342 | 1:20:chronic_disease,, | Renal insufficiency (creatinine > 1.5 mg/dL) | 3 | [
"Renal",
"insufficiency",
"(",
"creatinine",
">",
"1.5",
"mg/dL",
")"
] | [
2,
2,
0,
0,
0,
0,
0,
0
] |
NCT02724540 | 1:20:chronic_disease | portal hypertension with hepatofugal flow | 3 | [
"portal",
"hypertension",
"with",
"hepatofugal",
"flow"
] | [
2,
2,
0,
0,
0
] |
NCT01804634 | 7:26:chronic_disease | Minor ABO incompatibility | 3 | [
"Minor",
"ABO",
"incompatibility"
] | [
0,
2,
2
] |
NCT01880567 | 17:20:cancer,45:67:chronic_disease,104:115:chronic_disease,117:141:chronic_disease,145:166:chronic_disease,,246:261:chronic_disease, | Newly diagnosed MCL: Clinically significant cardiovascular disease such as uncontrolled or symptomatic arrhythmias, congestive heart failure or myocardial infarction within 6 months at the time of consent or any class 3 (moderate) or 4 (severe) cardiac disease defined by the New York Heart Association Classification | 3 | [
"Newly",
"diagnosed",
"MCL",
":",
"Clinically",
"significant",
"cardiovascular",
"disease",
"such",
"as",
"uncontrolled",
"or",
"symptomatic",
"arrhythmias",
",",
"congestive",
"heart",
"failure",
"or",
"myocardial",
"infarction",
"within",
"6",
"months",
"at",
"the... | [
0,
0,
3,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
2,
0,
2,
2,
2,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02568267 | 34:54:treatment | Current participation in another therapeutic clinical trial | 3 | [
"Current",
"participation",
"in",
"another",
"therapeutic",
"clinical",
"trial"
] | [
0,
0,
0,
0,
1,
1,
0
] |
NCT02132598 | 7:16:chronic_disease,76:132:treatment,,174:187:treatment | Other disorders associated with a high risk of fistula formation including Percutaneous Endoscopic Gastrostomy (PEG) tube placement within 3 months before the first dose of study therapy | 3 | [
"Other",
"disorders",
"associated",
"with",
"a",
"high",
"risk",
"of",
"fistula",
"formation",
"including",
"Percutaneous",
"Endoscopic",
"Gastrostomy",
"(",
"PEG",
")",
"tube",
"placement",
"within",
"3",
"months",
"before",
"the",
"first",
"dose",
"of",
"study... | [
0,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
1,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1
] |
NCT00409435 | 13:36:chronic_disease | Symptoms of orthostatic intolerance | 3 | [
"Symptoms",
"of",
"orthostatic",
"intolerance"
] | [
0,
0,
2,
2
] |
NCT02411656 | ,,237:247:treatment, | Subjects of childbearing potential should be willing to use effective methods of birth control or be surgically sterile, or abstain from heterosexual activity for the course of the study through at least 4 months after the last dose of study drug; subjects of childbearing potential are those who have not been surgicall... | 3 | [
"Subjects",
"of",
"childbearing",
"potential",
"should",
"be",
"willing",
"to",
"use",
"effective",
"methods",
"of",
"birth",
"control",
"or",
"be",
"surgically",
"sterile",
",",
"or",
"abstain",
"from",
"heterosexual",
"activity",
"for",
"the",
"course",
"of",
... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0... |
NCT03001830 | 13:23:treatment, | Received an AAV vector, or any other gene transfer agent in the previous 6 months | 3 | [
"Received",
"an",
"AAV",
"vector",
",",
"or",
"any",
"other",
"gene",
"transfer",
"agent",
"in",
"the",
"previous",
"6",
"months"
] | [
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02122081 | 30:58:cancer,60:94:cancer,99:130:cancer,,151:162:cancer,166:178:cancer, | Patients with a diagnosis of acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), or myelodysplastic syndromes (MDS) with fewer than 10% myeloblasts or lymphoblasts in the bone marrow and no blasts in the peripheral blood on morphologic analysis performed within 30 days of start of the conditioning regimen | 3 | [
"Patients",
"with",
"a",
"diagnosis",
"of",
"acute",
"myeloid",
"leukemia",
"(",
"AML",
")",
",",
"acute",
"lymphoblastic",
"leukemia",
"(",
"ALL",
")",
",",
"or",
"myelodysplastic",
"syndromes",
"(",
"MDS",
")",
"with",
"fewer",
"than",
"10",
"%",
"myelob... | [
0,
0,
0,
0,
0,
3,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3,
3,
0,
0,
0,
0,
0,
0,
0,
3,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02577406 | 14:39:chronic_disease,,,, | Subjects has uncontrolled hypertension (systolic blood pressure [BP] > 180 mmHg or diastolic BP > 100 mmHg) | 3 | [
"Subjects",
"has",
"uncontrolled",
"hypertension",
"(",
"systolic",
"blood",
"pressure",
"[",
"BP",
"]",
">",
"180",
"mmHg",
"or",
"diastolic",
"BP",
">",
"100",
"mmHg",
")"
] | [
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02257424 | 45:60:treatment,106:136:chronic_disease,171:193:chronic_disease,203:237:treatment | Patients must be able to swallow and retain oral medication and must not have any clinically significant gastrointestinal abnormalities that may alter absorption such as malabsorption syndrome or major resection of the stomach or bowels | 3 | [
"Patients",
"must",
"be",
"able",
"to",
"swallow",
"and",
"retain",
"oral",
"medication",
"and",
"must",
"not",
"have",
"any",
"clinically",
"significant",
"gastrointestinal",
"abnormalities",
"that",
"may",
"alter",
"absorption",
"such",
"as",
"malabsorption",
"s... | [
0,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
1,
1,
1,
1,
1,
1
] |
NCT03016351 | 1:17:chronic_disease | Seizure disorder | 3 | [
"Seizure",
"disorder"
] | [
2,
2
] |
NCT02419495 | 33:50:chronic_disease | Evidence of complete or partial bowel obstruction | 3 | [
"Evidence",
"of",
"complete",
"or",
"partial",
"bowel",
"obstruction"
] | [
0,
0,
0,
0,
0,
2,
2
] |
NCT02451553 | 1:22:treatment,,, | Prothrombin time (PT) (or international normalized ratio [INR]) and partial thromboplastin time (PTT) =< 1.5 x ULN | 3 | [
"Prothrombin",
"time",
"(",
"PT",
")",
"(",
"or",
"international",
"normalized",
"ratio",
"[",
"INR",
"]",
")",
"and",
"partial",
"thromboplastin",
"time",
"(",
"PTT",
")",
"=",
"<",
"1.5",
"x",
"ULN"
] | [
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03181048 | 20:23:treatment | Patients receiving PAO for acetabular retroversion in the absence of DDH | 3 | [
"Patients",
"receiving",
"PAO",
"for",
"acetabular",
"retroversion",
"in",
"the",
"absence",
"of",
"DDH"
] | [
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02693990 | 76:92:chronic_disease,106:130:chronic_disease,132:156:chronic_disease,158:176:chronic_disease | Uncontrolled intercurrent illness including, but not limited to ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements | 3 | [
"Uncontrolled",
"intercurrent",
"illness",
"including",
",",
"but",
"not",
"limited",
"to",
"ongoing",
"or",
"active",
"infection",
",",
"symptomatic",
"congestive",
"heart",
"failure",
",",
"unstable",
"angina",
"pectoris",
",",
"cardiac",
"arrhythmia",
",",
"or"... | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2,
2,
0,
0,
2,
2,
2,
0,
2,
2,
2,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT00909909 | 48:60:treatment | Breast considered technically satisfactory for radiotherapy | 3 | [
"Breast",
"considered",
"technically",
"satisfactory",
"for",
"radiotherapy"
] | [
0,
0,
0,
0,
0,
1
] |
NCT02296684 | 20:36:chronic_disease,53:77:treatment,,114:124:treatment,158:183:treatment,,225:232:treatment | Has a diagnosis of immunodeficiency or is receiving systemic steroid therapy (in dosing exceeding 10 mg daily of prednisone equivalent) or any other form of immunosuppressive therapy within 7 days prior to the first dose of MK-3475 | 3 | [
"Has",
"a",
"diagnosis",
"of",
"immunodeficiency",
"or",
"is",
"receiving",
"systemic",
"steroid",
"therapy",
"(",
"in",
"dosing",
"exceeding",
"10",
"mg",
"daily",
"of",
"prednisone",
"equivalent",
")",
"or",
"any",
"other",
"form",
"of",
"immunosuppressive",
... | [
0,
0,
0,
0,
2,
0,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1
] |
NCT02035085 | 19:22:treatment | Unable to undergo MRI | 3 | [
"Unable",
"to",
"undergo",
"MRI"
] | [
0,
0,
0,
1
] |
NCT02946892 | 24:45:treatment,47:77:treatment,82:108:treatment, | anticipated to undergo heart transplantation, interventional catheterization, or corrective cardiac surgery during the 7 months following entry into the study | 3 | [
"anticipated",
"to",
"undergo",
"heart",
"transplantation",
",",
"interventional",
"catheterization",
",",
"or",
"corrective",
"cardiac",
"surgery",
"during",
"the",
"7",
"months",
"following",
"entry",
"into",
"the",
"study"
] | [
0,
0,
0,
1,
1,
0,
1,
1,
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02553642 | 34:39:cancer,,256:265:treatment,296:302:treatment | In the case that a patient had a tumor sample acquired prior to consenting to the study and this tumor sample is acceptable for processing as described in Appendix 4 (i.e. frozen sample stored) and the tumor sample was acquired within 60 days of starting treatment, this is acceptable and a new biopsy will not be requir... | 3 | [
"In",
"the",
"case",
"that",
"a",
"patient",
"had",
"a",
"tumor",
"sample",
"acquired",
"prior",
"to",
"consenting",
"to",
"the",
"study",
"and",
"this",
"tumor",
"sample",
"is",
"acceptable",
"for",
"processing",
"as",
"described",
"in",
"Appendix",
"4",
... | [
0,
0,
0,
0,
0,
0,
0,
0,
3,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0
] |
NCT02424968 | 31:41:cancer,52:64:treatment,68:77:treatment,100:109:treatment | Must not have developed a new malignancy requiring chemotherapy or radiation in the interval since apheresis for initial hematocrit (HCT) | 3 | [
"Must",
"not",
"have",
"developed",
"a",
"new",
"malignancy",
"requiring",
"chemotherapy",
"or",
"radiation",
"in",
"the",
"interval",
"since",
"apheresis",
"for",
"initial",
"hematocrit",
"(",
"HCT",
")"
] | [
0,
0,
0,
0,
0,
0,
3,
0,
1,
0,
1,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0
] |
NCT02681211 | 102:110:chronic_disease | Patients with underlying abnormal brain pathology (e.g. mass or bleed) as the potential cause of the migraine | 3 | [
"Patients",
"with",
"underlying",
"abnormal",
"brain",
"pathology",
"(",
"e.g",
".",
"mass",
"or",
"bleed",
")",
"as",
"the",
"potential",
"cause",
"of",
"the",
"migraine"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
2
] |
NCT03115463 | 22:53:chronic_disease | Prenatally diagnosed congenital diaphragmatic hernia | 3 | [
"Prenatally",
"diagnosed",
"congenital",
"diaphragmatic",
"hernia"
] | [
0,
0,
2,
2,
2
] |
NCT02442297 | 17:30:treatment, | Steroid dose of dexamethasone greater than 2 mg per day (or equivalent) | 3 | [
"Steroid",
"dose",
"of",
"dexamethasone",
"greater",
"than",
"2",
"mg",
"per",
"day",
"(",
"or",
"equivalent",
")"
] | [
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02122328 | 1:28:chronic_disease | intraventricular hemorrhage | 3 | [
"intraventricular",
"hemorrhage"
] | [
2,
2
] |
NCT02907983 | 28:47:chronic_disease,76:92:chronic_disease,94:110:chronic_disease,115:148:chronic_disease | conditions that can affect depressive symptoms (e.g., current diagnosis of major depression, bipolar disorder, or other Axis I Psychiatric disorder) | 3 | [
"conditions",
"that",
"can",
"affect",
"depressive",
"symptoms",
"(",
"e.g.",
",",
"current",
"diagnosis",
"of",
"major",
"depression",
",",
"bipolar",
"disorder",
",",
"or",
"other",
"Axis",
"I",
"Psychiatric",
"disorder",
")"
] | [
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
2,
2,
0,
2,
2,
0,
0,
2,
2,
2,
2,
2,
0
] |
NCT02266329 | 8:39:treatment,44:77:treatment,87:94:treatment, | Use of supplements containing nitrates and supplements containing stimulants (such as ephedra) within 2 weeks of beginning the preliminary screening period through the end of study involvement | 3 | [
"Use",
"of",
"supplements",
"containing",
"nitrates",
"and",
"supplements",
"containing",
"stimulants",
"(",
"such",
"as",
"ephedra",
")",
"within",
"2",
"weeks",
"of",
"beginning",
"the",
"preliminary",
"screening",
"period",
"through",
"the",
"end",
"of",
"stu... | [
0,
0,
1,
1,
1,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02695433 | 1:9:chronic_disease | Diabetes | 3 | [
"Diabetes"
] | [
2
] |
NCT02656706 | 21:27:chronic_disease,37:49:treatment,51:68:treatment,70:83:treatment,88:104:treatment | Currently receiving cancer therapy (chemotherapy, radiation therapy, immunotherapy, or biologic therapy) or investigational anti-cancer drug | 3 | [
"Currently",
"receiving",
"cancer",
"therapy",
"(",
"chemotherapy",
",",
"radiation",
"therapy",
",",
"immunotherapy",
",",
"or",
"biologic",
"therapy",
")",
"or",
"investigational",
"anti-cancer",
"drug"
] | [
0,
0,
2,
0,
0,
1,
0,
1,
1,
0,
1,
0,
0,
1,
1,
0,
0,
0,
0,
0
] |
NCT02408861 | 45:70:treatment,155:162:treatment,170:177:treatment,, | participants will be eligible regardless of antiretroviral medication (including no antiretroviral medication) provided there is no intention to initiate therapy or the regimen has been stable for at least 4 weeks with no intention to change the regimen within 12 weeks following enrollment | 3 | [
"participants",
"will",
"be",
"eligible",
"regardless",
"of",
"antiretroviral",
"medication",
"(",
"including",
"no",
"antiretroviral",
"medication",
")",
"provided",
"there",
"is",
"no",
"intention",
"to",
"initiate",
"therapy",
"or",
"the",
"regimen",
"has",
"be... | [
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
1,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT02261519 | 30:45:treatment,49:66:treatment,55:65:treatment,87:100:chronic_disease,151:175:treatment, | Initiation or dose change of benzodiazepines or sleep medications due to worsening of schizophrenia symptoms or medication side effects, or any other psychotropic medications within 4 weeks prior to screening | 3 | [
"Initiation",
"or",
"dose",
"change",
"of",
"benzodiazepines",
"or",
"sleep",
"medications",
"due",
"to",
"worsening",
"of",
"schizophrenia",
"symptoms",
"or",
"medication",
"side",
"effects",
",",
"or",
"any",
"other",
"psychotropic",
"medications",
"within",
"4"... | [
0,
0,
0,
0,
0,
1,
0,
1,
1,
0,
0,
0,
0,
2,
0,
0,
1,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0
] |
NCT01220583 | 29:41:chronic_disease | No significant pre-existing hearing loss, as defined by the patient or treating physician | 3 | [
"No",
"significant",
"pre-existing",
"hearing",
"loss",
",",
"as",
"defined",
"by",
"the",
"patient",
"or",
"treating",
"physician"
] | [
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
0,
0
] |
NCT03171168 | 28:49:chronic_disease | Patients with diagnosis of neuromuscular disease | 3 | [
"Patients",
"with",
"diagnosis",
"of",
"neuromuscular",
"disease"
] | [
0,
0,
0,
0,
2,
2
] |
NCT02487095 | 23:32:treatment,43:59:cancer,70:83:chronic_disease,102:117:treatment,,156:164:treatment | subjects who have had treatment for their brain metastasis and whose brain disease is stable without steroid therapy for 1 week or on physiologic doses of steroids may be enrolled | 3 | [
"subjects",
"who",
"have",
"had",
"treatment",
"for",
"their",
"brain",
"metastasis",
"and",
"whose",
"brain",
"disease",
"is",
"stable",
"without",
"steroid",
"therapy",
"for",
"1",
"week",
"or",
"on",
"physiologic",
"doses",
"of",
"steroids",
"may",
"be",
... | [
0,
0,
0,
0,
1,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0,
1,
1,
0,
0,
0,
0,
0,
0,
0,
0,
1,
0,
0,
0
] |
NCT02844907 | 1:25:chronic_disease | Congestive heart failure | 3 | [
"Congestive",
"heart",
"failure"
] | [
2,
2,
2
] |
NCT02214589 | 1:20:chronic_disease | Chromosomal anomaly | 3 | [
"Chromosomal",
"anomaly"
] | [
2,
2
] |
NCT02769611 | 25:46:chronic_disease, | Patients who have had a myocardial infarction within 30 days prior to study enrollment | 3 | [
"Patients",
"who",
"have",
"had",
"a",
"myocardial",
"infarction",
"within",
"30",
"days",
"prior",
"to",
"study",
"enrollment"
] | [
0,
0,
0,
0,
0,
2,
2,
0,
0,
0,
0,
0,
0,
0
] |
NCT02309580 | 1:24:treatment,34:55:treatment,61:74:treatment | Treatment with warfarin or other Vitamin K antagonists (eg, phenprocoumon) | 3 | [
"Treatment",
"with",
"warfarin",
"or",
"other",
"Vitamin",
"K",
"antagonists",
"(",
"eg",
",",
"phenprocoumon",
")"
] | [
1,
1,
1,
0,
0,
1,
1,
1,
0,
0,
0,
1,
0
] |
NCT03113825 | 65:81:cancer | Current diagnosis of any other active or clinically significant nonbreast cancer | 3 | [
"Current",
"diagnosis",
"of",
"any",
"other",
"active",
"or",
"clinically",
"significant",
"nonbreast",
"cancer"
] | [
0,
0,
0,
0,
0,
0,
0,
0,
0,
3,
3
] |
NCT02353728 | 1:26:chronic_disease | Impaired cardiac function | 3 | [
"Impaired",
"cardiac",
"function"
] | [
2,
2,
2
] |
NCT02587598 | 35:38:cancer,65:87:treatment,99:121:treatment,126:145:chronic_disease | Subjects with relapsed/refractory AML must have received either induction chemotherapy for AML or hypomethylating agents for hematologic disease before AML | 3 | [
"Subjects",
"with",
"relapsed/refractory",
"AML",
"must",
"have",
"received",
"either",
"induction",
"chemotherapy",
"for",
"AML",
"or",
"hypomethylating",
"agents",
"for",
"hematologic",
"disease",
"before",
"AML"
] | [
0,
0,
0,
3,
0,
0,
0,
0,
1,
1,
0,
0,
0,
1,
1,
0,
2,
2,
0,
0
] |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.